XORTX Therapeutics Inc. (XRTX.V) TSXV

1.08

+0(+0.00%)

Updated at September 26 09:59AM

Currency In CAD

Valuation

Market Cap4.86M
Enterprise Value1.36M
P/E Ratio-1.56
PEG Ratio0.02
Price/Sales Ratio0
Price/Book Ratio1.45
Enterprise/Revenue0
Enterprise/EBITDA-0.6

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.69
Return On Equity-0.73

Income Statement

Revenue0
Revenue/Share0
Gross Profit-160,660
EBITDA-4.38M
Net Income-4.54M
Diluted EPS-1.58

Balance Sheet

Total Cash1.06M
Total Cash/Share0.28
Total Debt80,473
Total Debt/Equity0.04
Current Ratio1.78
Book Value Per Share0.54

Price History

52-Week Change-49.77
52-Week High3.46
52-Week Low0.91
Moving Average 50 Days1.14
Moving Average 200 Days1.33

Statistics

Average Volume2,514
Shares Outstanding3.79M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:9
Last Split DateNovember 14, 2023